Cognex (CGNX) director boosts holdings through RSU grant and conversion

Rhea-AI Filing Summary

COGNEX CORP director Angelos Papadimitriou reported equity awards and conversions. On February 18, 2026, he exercised 8,324 restricted stock units at $0.0000 per share into the same number of common shares, bringing his direct common stock holdings to 17,835 shares. On February 17, 2026, he received a grant of 4,817 restricted stock units, which each represent a contingent right to one Cognex common share and vest 100% on the first anniversary of the grant date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Papadimitriou Angelos

(Last) (First) (Middle)

1 VISION DRIVE

(Street)

NATICK MA 01760

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COGNEX CORP [ CGNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/18/2026		M		8,324	A	$0.0	17,835	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	$0.0(1)	02/18/2026		M			8,324	02/18/2026(2)	02/18/2026	Common Stock	8,324	$0.0	0	D
Restricted Stock Unit	$0.0(1)	02/17/2026		A		4,817		02/17/2027(3)	02/17/2027	Common Stock	4,817	$0.0	4,817	D
Restricted Stock Unit	$0.0							02/21/2024	02/21/2026	Common Stock	2,537		2,537	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.

2. The restricted stock units vest 100% on the first anniversary of the grant date (February 18, 2025).

3. The restricted stock units vest 100% on the first anniversary of the grant date (February 17, 2026).

	Angelos Papadimitriou	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Cognex (CGNX) director Angelos Papadimitriou report?

Angelos Papadimitriou reported equity-related transactions involving restricted stock units and common stock. He exercised 8,324 restricted stock units into common shares and received a new grant of 4,817 restricted stock units, all held as direct ownership in Cognex.

How many Cognex (CGNX) shares does Angelos Papadimitriou hold after these Form 4 transactions?

After the reported transactions, Angelos Papadimitriou directly holds 17,835 shares of Cognex common stock. This reflects the exercise of 8,324 restricted stock units into common shares, as disclosed, and is shown as his total direct common stock ownership following the transaction.

What restricted stock unit grant did Cognex (CGNX) report for Angelos Papadimitriou?

Cognex reported that Angelos Papadimitriou received a grant of 4,817 restricted stock units. Each unit represents a contingent right to receive one share of Cognex common stock and vests 100% on the first anniversary of the grant date, February 17, 2026.

When do Angelos Papadimitriou’s Cognex (CGNX) restricted stock units vest?

The filing notes one RSU grant vesting 100% on February 18, 2025, and another grant of 4,817 restricted stock units vesting 100% on February 17, 2026. Upon vesting, each unit entitles the holder to receive one share of Cognex common stock.

Did the Cognex (CGNX) Form 4 show any open-market buying or selling by Angelos Papadimitriou?

The reported transactions involve the exercise or conversion of restricted stock units and a new restricted stock unit grant. The filing does not show open-market purchases or sales; instead, it details equity awards and their conversion into Cognex common stock.

What is the transaction code used in the Cognex (CGNX) Form 4 for Angelos Papadimitriou’s activities?

The Form 4 uses transaction code “M” for the exercise or conversion of derivative securities into common stock and code “A” for a grant or award of restricted stock units. These codes indicate derivative exercises and equity grants, rather than open-market trades.